Skip to main
RVTY
RVTY logo

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Revvity is expected to experience solid performance in its Life Sciences reagents and Signal Software businesses, with an annual projected growth of 9-11%. The company is also expected to show Long-term (LT) growth of 6-8%, as it capitalizes on its strong diagnostics portfolio, emerging growth areas in pharmaceutical research and allows for expansion potential in e-commerce. Despite current macro pressures, Revvity anticipates a return to positive growth in both biotechnology and diagnostic market sectors, suggesting a healthy financial outlook.

Bears say

Revvity is facing flat earnings per share (EPS) forecasts and diminished operating margin expectations despite growth in its Diagnostics segment. The company adjusted its revenue guidance downwards, from $2.80B-$2.85B to $2.72B-$2.74B, and decreasing its EPS guidance from $4.70-$4.90 to $4.53-$4.57, largely as a result of diminished demand in the Life Sciences segment, specifically, a weaker demand for reagents in the pharma and biotech markets. Moreover, Revvity's future performance may be hampered further by poor economic conditions, industry funding cuts across multiple geographies, and macroeconomic headwinds that lead to slow customer demand for the company's products and services.

Revvity Inc (RVTY) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Revvity Inc (RVTY) has a Strong Buy consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $110, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $110, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.